Attribute ranging as a coordinated strategy between drug substance and drug product to accelerate commercial process nomination.
Hartmanshenn C, Bechtold A, Kwok T, Mora J, Contrella N, Confer A, Bade R, Andreani T, Hughes JME, Chen B, Sirota E, Codan L, Lamberto DJ, Xu Y, Salehi N, Crowley S.
Hartmanshenn C, et al. Among authors: crowley s.
J Pharm Sci. 2024 Dec 5:S0022-3549(24)00513-6. doi: 10.1016/j.xphs.2024.11.008. Online ahead of print.
J Pharm Sci. 2024.
PMID: 39645078